Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.35 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.35 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.35 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1970199 | 0.86 | PDE2A (0.52) | PDE2AKDM1AHAO1PTGS1AKR1C3 | |
| SCHEMBL17431619 | 0.84 | NFE2L2 (0.56) | NFE2L2PTGS1 | |
| SCHEMBL17431626 | 0.76 | PDE2A (0.46) | PDE2AKDM1AHAO1PTGS1AKR1C3 | |
| SCHEMBL12353987 | 0.75 | CA1 (0.36) | PDE2ACA1CA2CA7CA9 | |
| SCHEMBL4622815 | 0.73 | CYP1A2 (0.52) | PDE2ACA9 | |
| SCHEMBL2900759 | 0.71 | PDE2A (0.42) | PDE2AKDM1AIDO1HAO1PTGS1 | |
| SCHEMBL240645 | 0.71 | MEN1 (0.50) | PDE2AACHEKDM1ALOXL2TAAR1 | |
| SCHEMBL944658 | 0.71 | LMNA (0.50) | PDE2AKDM1AIDO1CES2CES1 | |
| SCHEMBL472361 | 0.71 | PDE2A (0.42) | PDE2ACA1CA2KDM1AHAO1 | |
| SCHEMBL21585264 | 0.71 | PDE2A (0.48) | PDE2AKDM1AHAO1PTGS1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113571775-B | Carbonate electrolyte additive and application thereof | 厦门大学 | 2023-02-14 | — | — | CN | claimed |
| CN-113571775-A | Carbonate electrolyte additive and application thereof | 厦门大学 | 2021-10-29 | — | — | CN | claimed |
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2023-11-21 | — | — | US | disclosed |
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3954387-B1 | NOVEL COMPOUND HAVING PD-L1 EXPRESSION-SUPPRESSING ACTION | UNIV TOHOKU (JP) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023204021-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE | ＡＧＣ株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023204020-A1 | COMPOUND, COMPOSITION, SURFACE TREATING AGENT, METHOD FOR PRODUCING ARTICLE, AND ARTICLE | ＡＧＣ株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023146513-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146513-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146512-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| CN-116406231-A | Molecules having certain pesticidal utility, and intermediates, compositions and methods related thereto | 科迪华农业科技有限责任公司 | 2023-07-07 | — | — | CN | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| WO-2008118787-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM & T RESEARCH, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| EP-0738713-B1 | Process for the preparation of pesticidal 1-(chloroaryl)heterocyclic compounds | RHONE POULENC AGROCHIMIE (FR) | 2000-02-09 | — | — | EP | disclosed |
| US-5726324-A | 1-(nitroaryl)pyrrole intermediates to pesticidal 1-(haloaryl)pyrroles | RHONE-POULENC INC. (US) | 1998-03-10 | — | — | US | disclosed |
| US-5631381-A | Process for the preparation of pesticidal 1-(haloaryl) heterocyclic compounds | RHONE-POULENC INC. (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0738713-A1 | Process for the preparation of pesticidal 1-(haloaryl)heterocyclic compounds | RHONE-POULENC AGROCHIMIE (FR) | 1996-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | BET1, BRD4, BRD3 | PDE2A 2367/4885CA1 4842/4885CA2 4753/4885 |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | PFAS, MPST, ARSA | PDE2A 4546/4885CA1 2632/4885CA2 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.